Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01571713 · ClinicalTrials.gov registry record
Side Effects of Pulmonary Hypertension Medications
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 250
- Enrollment target
NCT01571713: Completed study, sponsored by Stanford University.
NCT01571713 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01571713 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The study seeks to analyze the patient reported effects of pulmonary hypertension medications and compare these with the side effects described on the package inserts. Side effects for these PH medications have been described in the adult population, but have never been described in the pediatric population. This information can better improve patient care and be used to characterize the side effects resultant from these medications.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2011-08 |
| Est. Completion | 2020-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01571713
The ClinicalTrials.gov registry entry for NCT01571713 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01571713 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01571713 about?
NCT01571713 is a clinical study titled "Side Effects of Pulmonary Hypertension Medications". The study seeks to analyze the patient reported effects of pulmonary hypertension medications and compare these with the side effects described on the package inserts. Side effects for these PH medications have been described in the adult population, but have never been described in the pediatric po...
What is the current status of trial NCT01571713?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2011-08. Estimated completion is 2020-12.
Who is sponsoring clinical trial NCT01571713?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.